Luigi Gargiulo, Carlo Alberto Vignoli, Luciano Ibba, Andrea Cortese, Mario Valenti, Antonio Costanzo, & Alessandra Narcisi. (2023). Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: A 52-week single-center retrospective study. Taylor & Francis Group.
Chicago Style (17th ed.) CitationLuigi Gargiulo, Carlo Alberto Vignoli, Luciano Ibba, Andrea Cortese, Mario Valenti, Antonio Costanzo, and Alessandra Narcisi. Real-life Effectiveness and Safety of Dupilumab in Adolescents with Atopic Dermatitis: A 52-week Single-center Retrospective Study. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationLuigi Gargiulo, et al. Real-life Effectiveness and Safety of Dupilumab in Adolescents with Atopic Dermatitis: A 52-week Single-center Retrospective Study. Taylor & Francis Group, 2023.